Among the companies whose shares are expected to actively trade in Tuesday's session are Avon Products Inc. (AVP), Michael Kors Holdings Ltd.'s (KORS) and Hospira Inc. (HSP).
Avon Products' shares shed 4.2% to $16.80 premarket after the beauty products seller reported fourth-quarter results that missed expectations, with gross margins declining as a result of commodity cost pressures and an inventory-related charge in Brazil.
Michael Kors' fiscal third-quarter earnings rose 47% as the high-end apparel designer's revenue grew more than expected. Shares were trading 8.6% higher at $36.50 premarket as the company's profit also beat expectations.
Hospira swung to a fourth-quarter loss despite better-than-expected sales as charges related to the company's efforts to resolve quality-related issues at some of its plants weighed on results. Shares shed 3.6% to $33 premarket.
Insight Enterprises Inc.'s (NSIT) fourth-quarter earnings surged 39% as the informational technology services company reported sharply higher sales in its Asia Pacific region. Shares were up 12% at $21.24 premarket as the company easily beat earnings expectations and forecast upbeat 2012 income.
Perry Ellis International Inc. (PERY) has launched a review of its brand portfolio, a disclosure the retailer offered projected disappointing fiscal fourth-quarter results. Shares fell 7.5% to $15.50 premarket.
Ultra Clean Holdings' (UCTT) fourth-quarter earnings more than doubled after a tax benefit, though the supplier for original equipment manufacturers in the semiconductor, flat panel and other industries saw its revenue hurt by weak demand. Shares jumped 16% to $9.05 premarket.
Watson Pharmaceuticals Inc.'s (WPI) fourth-quarter earnings rose as the introduction of a generic version of Pfizer Inc.'s (PFE) cholesterol drug Lipitor and other products boosted sales. For 2012, the company raised its per-share earnings estimate. Shares climbed 2.2% to $59 premarket.
Masco Corp.'s (MAS) fourth-quarter loss narrowed as the building-products maker reported lower impairment charges as well as an income tax benefit, though the company's sales grew less-than-expected. Shares fell 4.8% to $12.60 premarket as Masco's adjusted loss also missed analyst expectations.
Zipcar Inc. (ZIP) swung to a larger-than-expected fourth-quarter profit as a jump in membership helped the car-sharing company book its second straight quarter of profitability. Revenue in the first quarter, which represents its slowest period seasonally, was pegged in the range of $58 million to $60 million. Wall Street is currently looking for $60 million. Shares shed 3.4% to $15.60 premarket.
DuPont Co. (DD) and Yingli Green Energy Holding Co. Ltd.'s (YGE) China subsidiary signed a $100 million deal to help increase the supply of photovoltaic materials for the adoption of solar energy. Yingli's American depositary shares declined 2.3% to $5.17, while Dupont was unchanged at $50.60 premarket.
Rackspace Hosting Inc.'s (RAX) fourth-quarter profit rose 85% as the company posted improved revenue and a larger customer base. Shares jumped 9.7% to $53.98 in premarket trading as results beat analyst expectations.
Health Management Associates Inc.'s (HMA) fourth-quarter earnings grew a stronger-than-expected 9.5% as the hospital operator generated more revenue per admission. Shares rose 7.3% to $7.40 premarket.
Fossil Inc.'s (FOSL) fourth-quarter earnings rose 22% though sales growth missed the watch and fashion-accessories retailer's lowered forecast and margins shrank. The company forecast per-share earnings below what analysts were expecting. Shares fell 6.6% to $97.60 premarket.
Biopharmaceutical firm Alnylam Pharmaceuticals Inc. (ALNY) said it would sell 7 million shares. Shares were down 7.2% at $11.50 premarket.
Magic Software Enterprises Ltd. (MGIC), a provider of mobile and cloud-enabled application and business integration platforms, said its fourth-quarter revenues increased 22% year-over-year as operating and net income both jumped more than 40% over the same period last year.
Calgon Carbon Corp. (CCC), which makes activated carbons and purification systems, said it expects its fourth-quarter revenue to miss analyst expectations and said its earnings for the quarter will be hurt by a slew of charges.
Charles River Laboratories International Inc. (CRL) swung to a fourth-quarter profit following prior-year write-downs of $395 million mostly related to its preclinical-services business. The drug-research services provider's latest results exceeded analysts' expectations.
FIS Inc.'s (FIS) fourth-quarter earnings rose 5.8% as the financial services company reported improved revenue in all three major segments, led by international solutions.
The U.S. Food and Drug Administration granted Gilead Sciences Inc.'s (GILD) antiretroviral drug Truvada a priority-review schedule, advancing what could become the first treatment labeled for HIV prevention.
Limelight Networks Inc.'s (LLNW) fourth-quarter loss widened slightly as the software-services company posted higher expenses, though revenue rose. The company's adjusted loss was better than analysts had expected.
Standard & Poor's Ratings Services raised its outlook on Meritor Inc. (MTOR) to positive from stable, citing expectations of sales growth in 2012.
Raymond James Financial Inc. (RJF) said it plans to sell 10.5 million shares, including one million shares offered by selling stockholders, to help fund its acquisition of brokerage Morgan Keegan & Co.
Western Union Co. (WU) unveiled a proposal to declassify its board structure and said it won't submit a management proposal for proxy access at its 2012 annual meeting.
-Edited by Corrie Driebusch and Drew FitzGerald; write to firstname.lastname@example.org and email@example.com